|1.||Mai, Antonello: 5 articles (01/2014 - 05/2010)|
|2.||Tsunoda, Tatsuhiko: 4 articles (08/2013 - 01/2010)|
|3.||Hamamoto, Ryuji: 4 articles (08/2013 - 01/2010)|
|4.||Nakamura, Yusuke: 4 articles (08/2013 - 01/2010)|
|5.||Kawamura, Akane: 3 articles (08/2015 - 01/2013)|
|6.||Harris, Adrian L: 3 articles (06/2015 - 10/2009)|
|7.||Yang, Jun: 3 articles (06/2015 - 10/2009)|
|8.||Xu, Xiu-E: 3 articles (03/2015 - 01/2013)|
|9.||Shen, Jin-Hui: 3 articles (03/2015 - 01/2013)|
|10.||Li, En-Min: 3 articles (03/2015 - 01/2013)|
03/01/2015 - "JMJD2B and JMJD2C, histone demethylases, play crucial roles in cancer development and are up-regulated in many cancers. "
01/01/2015 - "Accumulating evidence shows that histone demethylases play important roles in the regulation of pathological developmental processes in many diseases, including various types of cancers. "
01/01/2015 - "As AR complexes with histone lysine demethylases (KDMs) to regulate AR target genes in human cancers, we also investigated if the same mechanism is present in the ovine placenta. "
09/19/2014 - "Inhibition of histone demethylases has within recent years advanced into a new strategy for treating cancer and other diseases. "
06/01/2014 - "The Jumonji family: past, present and future of histone demethylases in cancer."
02/01/2015 - "Previous studies have indicated that several histone demethylases such as KDM3A, KDM4B, and KDM4C are regulated by hypoxia-inducible factor (HIF). "
08/01/2015 - "Epigenetic regulation by histone demethylases in hypoxia."
10/01/2009 - "Role of hypoxia-inducible factors in epigenetic regulation via histone demethylases."
12/26/2008 - "Here we show that the hypoxia-inducible factor HIF-1alpha binds to specific recognition sites in the genes encoding the jumonji family histone demethylases JMJD1A and JMJD2B and induces their expression. "
12/26/2008 - "The histone demethylases JMJD1A and JMJD2B are transcriptional targets of hypoxia-inducible factor HIF."
|3.||Prostatic Neoplasms (Prostate Cancer)
01/01/2012 - "The emerging role of histone lysine demethylases in prostate cancer."
06/01/2010 - "Genetic alterations and changes in expression of histone demethylases in prostate cancer."
01/09/2014 - "In prostate cancer, two different types of histone lysine demethylases (KDM), LSD1/KDM1 and JMJD2/KDM4, are coexpressed and colocalize with the androgen receptor. "
06/01/2010 - "Histone demethylases LSD1, JHDM2A, and GASC1 have been suggested to function as androgen receptor co-activators, and to be involved in prostate cancer (PC) progression. "
03/15/2015 - "GASC1, member of the histone demethylases affecting heterochromatin formation and transcriptional repression, has been found to be dysregulation in many types of cancers including breast cancer, prostate cancer, metastatic lung sarcomatoid carcinoma, and leukemia. "
|4.||Oxyphilic Adenoma (Oncocytoma)
11/02/2015 - "Hence, the main goal of this study was to identify differentially expressed histone methyltransferases (HMTs) and histone demethylases (HDMs) that might prove useful for RCT diagnosis and prognostication, emphasizing the discrimination between oncocytoma (a benign tumor) and renal cell carcinoma (RCC), especially the chromophobe subtype (chRCC). "
|5.||Neoplasm Metastasis (Metastasis)
|6.||Proteins (Proteins, Gene)
|7.||Histone Acetyltransferases (Histone Acetyltransferase)
|8.||Androgen Receptors (Androgen Receptor)
|9.||DNA (Deoxyribonucleic Acid)
|10.||Histone Deacetylases (Histone Deacetylase)